-
581“…The underlying imunosupression caused by SLE and long-term steroid treatment could have predisposed this patient to invasive Pneumococcal disease.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
582“…The disease course was complicated with severe myelitis and consequent paraplegia which is an extremely rare complication of pneumococcal disease.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
583por Makwana, Ashley, Ladhani, Shamez N., Kapatai, Georgia, Campion, Ella, Fry, Norman K., Sheppard, Carmen“…We observed a sudden and rapid increase in rare invasive pneumococcal disease serotype 7C, from an annual average of 3 cases during 2000–01 through 2015–16 to 29 cases in 2016–17. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
584“…Nationwide surveillance of invasive pneumococcal disease has been conducted in Germany since 1992. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
585por Earnshaw, Stephanie R, McDade, Cheryl L, Zanotti, Giovanni, Farkouh, Raymond A, Strutton, David“…CONCLUSIONS: Considering the epidemiology of pneumococcal disease in Canada, PCV13 is shown to be a cost-saving immunization program because it provides substantial public health and economic benefits relative to PCV10.…”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
586por Ayieko, Philip, Griffiths, Ulla K., Ndiritu, Moses, Moisi, Jennifer, Mugoya, Isaac K., Kamau, Tatu, English, Mike, Scott, J. Anthony G.“…We projected a 42.7% reduction in pneumococcal disease episodes leading to a US$1.97 million reduction in treatment costs and a 6.1% reduction in childhood mortality annually. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
587por Chen, Jieling, O’Brien, Megan A., Yang, H. Keri, Grabenstein, John D., Dasbach, Erik J.“…METHODS: A static cohort model that incorporated costs, health outcomes, and quality-adjusted life-year (QALY) losses associated with invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia (NBPP) was developed to evaluate seven pneumococcal vaccination strategies for a 50-year-old adult cohort over a 50-year period using incremental cost-effectiveness ratios (ICERs). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
588por Partouche, Henri, Buffel du Vaure, Céline, Personne, Virginie, Le Cossec, Chloé, Garcin, Camille, Lorenzo, Alain, Ghasarossian, Christian, Landais, Paul, Toubiana, Laurent, Gilberg, Serge“…More than a third of them were at increased risk for invasive pneumococcal disease. With or without X-rays, most patients received antibiotics and experienced uncomplicated disease progression.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
589por McLaughlin, John M., McGinnis, Justin J., Tan, Litjen, Mercatante, Annette, Fortuna, Joseph“…Adult VPDs examined were: (1) influenza, (2) pneumococcal disease (both invasive disease and pneumonia), (3) herpes zoster (shingles), and (4) pertussis (whooping cough). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
590por Raddaoui, Anis, Simões, Alexandra S., Baaboura, Rekaya, Félix, Sofia, Achour, Wafa, Ben Othman, Tarek, Béjaoui, Mohamed, Sá-Leão, Raquel, Ben Hassen, Assia“…BACKGROUND: Pneumococcal disease, a major cause of morbidity and mortality globally, has higher incidence among young children, the elderly and the immunocompromised of all ages. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
591por Rearte, Analía, Ruvinsky, Raul, Kupervaser, Judit, Gentile, Luis Fernando, Cafure, Maria Eugenia, Haidar, Adriana, Tito, Maria Elisa, Avaro, Federico, Cortiana, Cristina, Cozzani, Hugo, Veliz, Omar, Fossati, Sofia, Regueira, Mabel, Vizzotti, Carla“…We performed an epidemiological study in order to describe consolidated pneumonia and pneumococcal disease incidence following PCV-13 routine vaccination. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
592por Wateska, Angela R., Nowalk, Mary Patricia, Zimmerman, Richard K., Smith, Kenneth J., Lin, Chyongchiou J.“…BACKGROUND: Adults aged 18–64 years with comorbid conditions are at high risk for complications of certain vaccine-preventable diseases, including influenza and pneumococcal disease. The 4 Pillars™ Practice Transformation Program (4 Pillars Program) increases uptake of pneumococcal polysaccharide vaccine, influenza vaccine and tetanus-diphtheria-acellular pertussis vaccine by 5–10% among adults with high-risk medical conditions, but its cost-effectiveness is unknown. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
593por Vissers, Marloes, Wijmenga-Monsuur, Alienke J., Knol, Mirjam J., Badoux, Paul, van Houten, Marlies A., van der Ende, Arie, Sanders, Elisabeth A. M., Rots, Nynke Y.“…Data on carriage prevalence of S. pneumoniae serotypes in children and invasive pneumococcal disease (IPD) in children and older adults were collected to examine the impact of PCVs on carriage and IPD in The Netherlands. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
594por Shoji, Hisashi, Vázquez-Sánchez, Daniel A, Gonzalez-Diaz, Aida, Cubero, Meritxell, Tubau, Fe, Santos, Salud, García-Somoza, Dolores, Liñares, Josefina, Yuste, José, Martí, Sara, Ardanuy, Carmen“…CONCLUSION: The epidemiology of pneumococcal disease in COPD changed after the introduction of PCV13 in children. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
595por van Westen, Els, Knol, Mirjam J., Wijmenga-Monsuur, Alienke J., Tcherniaeva, Irina, Schouls, Leo M., Sanders, Elisabeth A. M., van Els, Cecile A. C. M., Berbers, Guy A. M., Rots, Nynke Y.“…IgG levels decline after vaccination and could become too low to prevent carriage acquisition and/or pneumococcal disease. We compared the levels of 10-valent (PCV10) and 13-valent (PCV13) pneumococcal vaccine induced serum IgG antibodies at multiple time points after primary vaccinations. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
596por Pugh, Sarah J., Fletcher, Mark A., Charos, Apostolos, Imekraz, Lynda, Wasserman, Matt, Farkouh, Raymond“…CONCLUSION: The ongoing NIP in Algeria is projected to reduce the impact and economic toll of pneumococcal disease in Algeria. If an NIP were also introduced in Tunisia, a commensurate impact would be expected. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
597por Schmedt, Niklas, Schiffner-Rohe, Julia, Sprenger, Ralf, Walker, Jochen, von Eiff, Christof, Häckl, Dennis“…To prevent pneumococcal disease in patients at high risk, further efforts are needed to increase awareness and improve the timeliness of pneumococcal vaccination.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
598por Hoang, Van-Thuan, Meftah, Mohammed, Anh Ly, Tran Duc, Drali, Tassadit, Yezli, Saber, Alotaibi, Badriah, Raoult, Didier, Parola, Philippe, Pommier de Santi, Vincent, Gautret, Philippe“…CONCLUSIONS: Pilgrims at risk for pneumococcal disease are more likely to suffer from febrile respiratory symptoms at the Hajj despite being immunized against pneumococcal disease and despite lowered S. pneumoniae carriage and should be targeted for reinforced prevention against respiratory infections.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
599por Smith, Emma L., Wheeler, India, Adler, Hugh, Ferreira, Daniela M., Sá-Leão, Raquel, Abdullahi, Osman, Adetifa, Ifedayo, Becker-Dreps, Sylvia, Esposito, Susanna, Farida, Helmia, Kandasamy, Rama, Mackenzie, Grant A., Nuorti, J. Pekka, Nzenze, Susan, Madhi, Shabir A., Ortega, Omar, Roca, Anna, Safari, Dodi, Schaumburg, Frieder, Usuf, Effua, Sanders, Elisabeth A.M., Grant, Lindsay R., Hammitt, Laura L., O'Brien, Katherine L., Gounder, Prabhu, Bruden, Dana J.T., Stanton, Michelle C., Rylance, Jamie“…BACKGROUND: Colonisation with Streptococcus pneumoniae can lead to invasive pneumococcal disease and pneumonia. Pneumococcal acquisition and prevalence of colonisation are high in children. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
600por Ceyhan, Mehmet, Aykac, Kubra, Gurler, Nezahat, Ozsurekci, Yasemin, Öksüz, Lütfiye, Altay Akısoglu, Özlem, Öz, Fatma Nur, Emiroglu, Melike, TurkDagi, Hatice, Yaman, Akgün, Söyletir, Güner, Öztürk, Candan, Akpolat, Nezahat, Özakin, Cüneyt, Aydın, Faruk, Aydemir, Şöhret, Kiremitci, Abdurrahman, Gültekin, Meral, Camcıoglu, Yıldız, Zer, Yasemin, Güdücüoğlu, Hüseyin, Gülay, Zeynep, Birinci, Asuman, Arabaci, Cigdem, Karbuz, Adem, Devrim, Ilker, Sorguc, Yelda, Baysan, Betil Özhak, Karadag Oncel, Eda, Yilmaz, Nisel, Altintop, Yasemin Ay“…Objectives: To determine the serotype distribution of pneumococcus causing invasive pneumococcal disease (meningitidis, bacteremia and empyema) in children in Turkey, and to observe potential changes in this distribution in time to guide effective vaccine strategies. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto